Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

ADPT

Adaptive Biotechnologies Corp

Apr 19 • 04:00PM ET

2.40

Dollar change +0.07
Percentage change 2.78	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: ARKG VTI VB IWM VBK VXF IBB IWO VTWO SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.56	Insider Own	4.54%	Shs Outstand	145.08M	Perf Week	-20.27%
Market Cap	348.22M	Forward P/E	-	EPS next Y	-1.08	Insider Trans	-2.68%	Shs Float	138.51M	Perf Month	-28.99%
Income	-225.25M	PEG	-	EPS next Q	-0.35	Inst Own	95.40%	Short Float	6.57%	Perf Quarter	-41.75%
Sales	170.28M	P/S	2.04	EPS this Y	16.01%	Inst Trans	-3.09%	Short Ratio	5.60	Perf Half Y	-42.17%
Book/sh	2.13	P/B	1.13	EPS next Y	17.65%	ROA	-29.68%	Short Interest	9.10M	Perf Year	-71.73%
Cash/sh	2.39	P/C	1.01	EPS next 5Y	21.60%	ROE	-58.31%	52W Range	2.33 - 9.08	Perf YTD	-51.02%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-32.91%	ROI	-42.62%	52W High	-73.57%	Beta	1.30
Dividend TTM	-	Quick Ratio	4.50	Sales past 5Y	27.46%	Gross Margin	42.57%	52W Low	3.00%	ATR (14)	0.27
Dividend Ex-Date	-	Current Ratio	4.66	EPS Y/Y TTM	-10.98%	Oper. Margin	-118.40%	RSI (14)	36.61	Volatility	11.80% 9.10%
Employees	709	Debt/Eq	0.74	Sales Y/Y TTM	-8.11%	Profit Margin	-132.29%	Recom	1.50	Target Price	6.67
Option/Short	Yes / Yes	LT Debt/Eq	0.71	EPS Q/Q	-70.84%	Payout	-	Rel Volume	1.44	Prev Close	2.34
Sales Surprise	-5.51%	EPS Surprise	-44.88%	Sales Q/Q	-17.05%	Earnings	Feb 14 AMC	Avg Volume	1.63M	Price	2.40
SMA20	-16.15%	SMA50	-29.18%	SMA200	-50.61%	Trades		Volume	2,341,465	Change	2.78%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-23	Resumed	JP Morgan	Overweight	$15
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$15
Dec-21-22	Upgrade	Piper Sandler	Neutral → Overweight	$7.50 → $14
Aug-25-22	Initiated	Credit Suisse	Underperform	$8
Jun-03-22	Initiated	Piper Sandler	Neutral	$7.50
Feb-16-22	Reiterated	JP Morgan	Overweight	$75 → $50
Feb-16-22	Reiterated	Goldman	Neutral	$54 → $21
Feb-16-22	Reiterated	BTIG Research	Buy	$35 → $30
Feb-16-22	Reiterated	BofA Securities	Buy	$40 → $32
Oct-15-21	Resumed	Cowen	Outperform
Mar-03-21	Downgrade	Goldman	Buy → Neutral	$74 → $63
Oct-08-20	Resumed	BTIG Research	Buy	$60
Sep-09-20	Initiated	Morgan Stanley	Equal-Weight	$42
Jun-03-20	Initiated	Goldman	Buy	$60
Jul-23-19	Initiated	BTIG Research	Buy	$46
Jul-22-19	Initiated	William Blair	Outperform
Jul-22-19	Initiated	Guggenheim	Buy	$47
Jul-22-19	Initiated	Goldman	Neutral	$32
Jul-22-19	Initiated	Cowen	Outperform
Jul-22-19	Initiated	BofA/Merrill	Buy	$45

Show Previous Ratings

Apr-17-24 04:05PM	Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024 (GlobeNewswire) -11.27%
Apr-02-24 04:05PM	Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue (GlobeNewswire)
Mar-27-24 04:30PM	The 7 Best Penny Stocks to Buy in Q2 2024 (InvestorPlace)
08:30AM	Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024 (GlobeNewswire)
Mar-11-24 12:01AM	Team behind popular Falcon AI models unveils new startup with $20 million in funding aimed at helping companies tailor LLMs for business (Fortune)
04:05PM	Loading…
Feb-22-24 04:05PM	Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference (GlobeNewswire)
Feb-15-24 10:09AM	Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:37AM	Q4 2023 Adaptive Biotechnologies Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-14-24 05:16PM	Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment (GuruFocus.com) +8.84%
04:43PM	Adaptive Biotechnologies: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-13-24 02:23AM	Here's Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4 (Insider Monkey) -7.65%
Feb-12-24 09:16AM	Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Jan-29-24 04:05PM	Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024 (GlobeNewswire)
Dec-27-23 04:05PM	Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
05:50AM	Loading…
Dec-12-23 05:50AM	Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You? (Motley Fool)
Dec-11-23 03:30PM	16 Best Penny Stocks To Buy For 2024 (Insider Monkey)
Dec-09-23 08:30AM	Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ in Patients with Blood Cancers at the 65th ASH Annual Meeting (GlobeNewswire)
Dec-05-23 07:30AM	Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting (GlobeNewswire) -7.14%
Nov-10-23 01:52PM	Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2023 Earnings Call Transcript (Insider Monkey) -18.18%
Nov-09-23 04:17PM	Adaptive Biotechnologies: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-07-23 07:30AM	Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ Assay Across BeiGene's Lymphoid Malignancy Pipeline (GlobeNewswire)
Nov-02-23 04:05PM	Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023 (GlobeNewswire) +9.46%
Oct-26-23 10:02AM	Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
Oct-17-23 07:57AM	Prothena (PRTA) Soars 18.7%: Is Further Upside Left in the Stock? (Zacks)
Sep-27-23 05:14AM	Strength Seen in Adaptive Biotechnologies (ADPT): Can Its 9.5% Jump Turn into More Strength? (Zacks)
Sep-13-23 07:30AM	Adaptive Announces Launch of Epic Integration for clonoSEQ® (GlobeNewswire)
Aug-30-23 04:30PM	Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-28-23 11:53PM	3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List (InvestorPlace)
10:29AM	Loading…
Aug-24-23 10:29AM	Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks (Motley Fool) -6.62%
Aug-02-23 05:35PM	Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:30PM	Adaptive Biotechnologies: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-29-23 12:12AM	Is it Still Worthy to Invest in Adaptive Biotechnologies (ADPT)? (Insider Monkey)
Jul-19-23 08:52AM	Viking Globals Performance, AUM, and Long-Term Stock Picks (Insider Monkey)
Jul-10-23 04:05PM	Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023 (GlobeNewswire) +8.28%
Jun-24-23 03:19PM	11 Best Medical Stocks Under $10 (Insider Monkey)
Jun-16-23 05:02PM	Why Shares of Adaptive Biotechnologies Jumped This Week (Motley Fool)
Jun-02-23 10:15AM	Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought (Motley Fool) +5.82%
07:34AM	Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assays Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer (GlobeNewswire)
May-29-23 08:08AM	Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss (Simply Wall St.)
May-26-23 09:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
May-24-23 04:05PM	Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences (GlobeNewswire) +6.42%
May-23-23 09:54AM	Too Cheap to Ignore: Cathie Wood Snaps Up These 2 Stocks Under $10 (TipRanks)
May-15-23 07:50AM	3 Personalized Medicine Stocks to Buy for Long-Time Returns (InvestorPlace)
May-12-23 08:00AM	Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-09-23 07:30AM	Adaptive Biotechnologies Announces FDA Acceptance of Genentechs Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology (GlobeNewswire) +6.21%
May-04-23 09:13AM	Q1 2023 Adaptive Biotechnologies Corp Earnings Call (Thomson Reuters StreetEvents) -14.27%
May-03-23 05:25PM	Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.99%
04:05PM	Adaptive Biotechnologies Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 10:02AM	Analysts Estimate Blueprint Medicines (BPMC) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-26-23 10:02AM	Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-25-23 04:05PM	Adaptive Biotechnologies to Participate in the BofA Securities 2023 Healthcare Conference (GlobeNewswire) -9.82%
Apr-24-23 09:40AM	Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Apr-18-23 12:10PM	Investors Still Waiting For A Pull Back In Adaptive Biotechnologies Corporation (NASDAQ:ADPT) (Simply Wall St.)
Apr-12-23 07:30AM	Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline (GlobeNewswire)
Apr-06-23 04:05PM	Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023 (GlobeNewswire)
Mar-29-23 04:20PM	11 Most Promising Gene Editing Stocks According to Analysts (Insider Monkey)
Mar-27-23 09:40AM	Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-16-23 11:41AM	Bellicum (BLCM) Down on Ending Development of CAR-T Candidates (Zacks)
Mar-10-23 10:42AM	Neoleukin (NLTX) Up 36% on Initiating Another Restructuring Plan (Zacks)
10:26AM	AstraZeneca (AZN) Posts Positive Data From Lung Cancer Studies (Zacks)
Mar-09-23 09:55AM	How Much Upside is Left in Adaptive Biotechnologies (ADPT)? Wall Street Analysts Think 49.94% (Zacks) -7.54%
09:40AM	Is Fulgent Genetics (FLGT) Outperforming Other Medical Stocks This Year? (Zacks)
Feb-28-23 11:11AM	Perrigo (PRGO) Beats Q4 Earnings Estimates, Lags on Sales (Zacks)
Feb-27-23 04:05PM	Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
Feb-24-23 11:52AM	Karuna (KRTX) Reports Narrower-Than-Expected Loss in Q4 (Zacks)
Feb-21-23 09:55AM	Can Adaptive Biotechnologies (ADPT) Climb 45.58% to Reach the Level Wall Street Analysts Expect? (Zacks) -7.37%
09:40AM	Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Feb-14-23 05:55PM	Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Jan-30-23 07:21AM	Companies Like Adaptive Biotechnologies (NASDAQ:ADPT) Are In A Position To Invest In Growth (Simply Wall St.)
Jan-23-23 04:05PM	Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023 (GlobeNewswire)
Jan-10-23 09:00AM	Capella Space Raises $60M in Growth Equity from the United States Innovative Technology Fund to Expand Satellite Imaging Capacity and Meet Rapidly Growing Customer Demand (PR Newswire)
Dec-27-22 04:05PM	Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-22 06:14AM	Adaptive Biotechnologies (NASDAQ:ADPT shareholders incur further losses as stock declines 17% this week, taking three-year losses to 76% (Simply Wall St.)
Dec-10-22 10:00AM	Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting (GlobeNewswire)
Dec-05-22 07:30AM	Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ® MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting (GlobeNewswire) -7.92%
Dec-01-22 07:30AM	Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using Circulating Tumor DNA (ctDNA) (GlobeNewswire)
Nov-21-22 04:05PM	Adaptive Biotechnologies to Participate in the Piper Sandler Healthcare Conference (GlobeNewswire)
07:30AM	New Survey Reveals the Majority of Myeloma Patients That Undergo Minimal Residual Disease (MRD) Testing Find a Clear Clinical or Emotional Benefit from Results (GlobeNewswire)
Nov-03-22 06:35PM	Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-11-22 08:05AM	Adaptive Announces Partnership with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers (GlobeNewswire)
Oct-05-22 04:05PM	Adaptive Biotechnologies to Report Third Quarter of 2022 Financial Results on November 3, 2022 (GlobeNewswire)
Sep-15-22 06:48AM	Institutional owners may consider drastic measures as Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) recent US$104m drop adds to long-term losses (Simply Wall St.)
Sep-14-22 05:22PM	Adaptive Biotechnologies to receive up to $250M in financing deal (American City Business Journals)
Sep-12-22 08:30AM	Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million (GlobeNewswire)
Sep-02-22 08:00AM	Adaptive Biotechnologies to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-14-22 11:13AM	3 Cathie Wood Stocks for the Future (Motley Fool)
Aug-04-22 12:00AM	Adaptive Biotechnologies Corporation (ADPT) Q2 2022 Earnings Call Transcript (Motley Fool) +14.86%
Aug-03-22 05:35PM	Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-02-22 10:07AM	Is a Surprise Coming for Adaptive Biotechnologies (ADPT) This Earnings Season? (Zacks)
Jul-28-22 10:02AM	Earnings Preview: NGM Biopharmaceuticals (NGM) Q2 Earnings Expected to Decline (Zacks)
09:48AM	Cathie Woods Top 15 Small-Cap Stock Picks (Insider Monkey)
07:30AM	Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma (GlobeNewswire)
Jul-27-22 10:01AM	Adaptive Biotechnologies (ADPT) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-18-22 06:56AM	Here's Why We're Watching Adaptive Biotechnologies' (NASDAQ:ADPT) Cash Burn Situation (Simply Wall St.) -6.09%

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
NEUPERT PETER M	Director	Mar 12 '24	Option Exercise	0.84	15,000	12,600	169,296	Mar 13 05:55 PM
ROBINS CHAD M	CEO and Chairman	Mar 05 '24	Sale	3.43	48,673	167,007	2,576,701	Mar 06 07:40 PM
RUBINSTEIN JULIE	President	Mar 05 '24	Sale	3.47	39,070	135,764	472,754	Mar 06 07:41 PM
BENZENO SHARON	Chief Commercial Ofc Imm Med	Mar 05 '24	Sale	3.44	29,390	100,994	327,415	Mar 06 07:42 PM
PETERSON TYCHO	Chief Financial Officer	Mar 05 '24	Sale	3.44	15,456	53,169	531,553	Mar 06 07:40 PM
LO FRANCIS	Chief People Officer	Mar 05 '24	Sale	3.43	14,700	50,439	253,745	Mar 06 07:42 PM
Taylor Stacy L	SVP and General Counsel	Mar 05 '24	Sale	3.43	13,381	45,963	166,287	Mar 06 07:42 PM
BOBULSKY SUSAN	Chief Commercial Officer, MRD	Mar 05 '24	Sale	3.44	12,991	44,629	248,290	Mar 06 07:39 PM
PISKEL KYLE	Principal Accounting Officer	Mar 05 '24	Sale	3.43	7,727	26,504	123,318	Mar 06 07:43 PM
NEUPERT PETER M	Director	Dec 13 '23	Option Exercise	0.84	100,000	84,000	122,968	Dec 15 04:21 PM
PISKEL KYLE	Principal Accounting Officer	Nov 16 '23	Sale	4.13	259	1,070	87,305	Nov 20 05:30 PM
SOOD NITIN	Chief Commercial Officer, MRD	Aug 08 '23	Sale	6.54	10,550	68,997	214,808	Aug 08 04:53 PM
SOOD NITIN	Chief Commercial Officer, MRD	Aug 07 '23	Sale	6.78	5,652	38,321	225,358	Aug 08 04:53 PM
PETERSON TYCHO	Chief Financial Officer	Jun 20 '23	Option Exercise	7.30	134,961	985,215	534,180	Jun 21 05:32 PM
PETERSON TYCHO	Chief Financial Officer	Jun 20 '23	Sale	8.14	134,961	1,098,583	399,219	Jun 21 05:32 PM
PETERSON TYCHO	Chief Financial Officer	Jun 15 '23	Option Exercise	7.30	14,328	104,594	413,547	Jun 20 05:41 PM
PETERSON TYCHO	Chief Financial Officer	Jun 15 '23	Sale	8.53	70,000	597,100	399,219	Jun 20 05:41 PM
PETERSON TYCHO	Chief Financial Officer	Jun 02 '23	Sale	7.16	38,000	272,080	454,891	Jun 06 04:23 PM

Open in Screener

TRUP

Trupanion Inc

Apr 19 • 04:00PM ET

22.45

Dollar change +1.09
Percentage change 5.10	%

Financial • Insurance - Specialty • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJR VTI VB IWM VXF VBK IWO IJS VTWO VIOO

Index	RUT	P/E	-	EPS (ttm)	-1.08	Insider Own	23.94%	Shs Outstand	41.86M	Perf Week	-3.98%
Market Cap	938.63M	Forward P/E	408.18	EPS next Y	0.06	Insider Trans	-0.11%	Shs Float	31.80M	Perf Month	-14.77%
Income	-44.69M	PEG	-	EPS next Q	-0.20	Inst Own	95.87%	Short Float	40.36%	Perf Quarter	-18.16%
Sales	1.11B	P/S	0.85	EPS this Y	58.33%	Inst Trans	4.86%	Short Ratio	18.13	Perf Half Y	-13.69%
Book/sh	7.26	P/B	3.09	EPS next Y	112.22%	ROA	-6.15%	Short Interest	12.83M	Perf Year	-37.22%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-14.68%	52W Range	18.45 - 37.71	Perf YTD	-26.42%
Dividend Est.	-	P/FCF	2607.32	EPS past 5Y	-106.11%	ROI	-10.36%	52W High	-40.47%	Beta	1.77
Dividend TTM	-	Quick Ratio	-	Sales past 5Y	29.66%	Gross Margin	-	52W Low	21.68%	ATR (14)	1.60
Dividend Ex-Date	-	Current Ratio	1.63	EPS Y/Y TTM	1.15%	Oper. Margin	-3.65%	RSI (14)	36.57	Volatility	6.88% 6.04%
Employees	1142	Debt/Eq	0.42	Sales Y/Y TTM	22.47%	Profit Margin	-4.03%	Recom	2.56	Target Price	33.25
Option/Short	Yes / Yes	LT Debt/Eq	0.42	EPS Q/Q	77.16%	Payout	-	Rel Volume	1.32	Prev Close	21.36
Sales Surprise	2.07%	EPS Surprise	72.22%	Sales Q/Q	20.26%	Earnings	Feb 15 AMC	Avg Volume	707.93K	Price	22.45
SMA20	-10.79%	SMA50	-16.14%	SMA200	-18.14%	Trades		Volume	932,514	Change	5.10%

Date	Action	Analyst	Rating Change	Price Target Change
May-08-23	Downgrade	BofA Securities	Buy → Neutral	$72 → $32
Sep-21-22	Initiated	Jefferies	Buy	$77
Aug-04-22	Downgrade	Piper Sandler	Overweight → Neutral	$80 → $69
Feb-24-22	Upgrade	BofA Securities	Neutral → Buy	$129 → $118
Nov-08-21	Downgrade	BofA Securities	Buy → Neutral	$112 → $129
Oct-18-21	Initiated	BofA Securities	Buy	$112
Oct-06-21	Initiated	Piper Sandler	Overweight	$110
Apr-06-21	Initiated	Evercore ISI	Outperform	$100
Aug-10-20	Downgrade	Guggenheim	Buy → Neutral
Aug-05-20	Downgrade	Northland Capital	Outperform → Market Perform	$42 → $50
Feb-14-20	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-09-20	Downgrade	Stifel	Buy → Hold	$32 → $38
Aug-16-19	Downgrade	Craig Hallum	Buy → Hold	$29
May-23-19	Initiated	Guggenheim	Buy	$35
Oct-02-18	Upgrade	CL King	Neutral → Buy
Sep-07-18	Initiated	Raymond James	Outperform
Aug-03-18	Reiterated	Stifel	Buy	$40 → $43
Aug-03-18	Reiterated	Lake Street	Buy	$41 → $46
Feb-14-18	Reiterated	Stifel	Buy	$33 → $34
Feb-14-18	Reiterated	Lake Street	Buy	$32 → $41

Show Previous Ratings

Today 11:02AM	12 Most Shorted Stocks in 2024 (Insider Monkey) +5.10%
09:00AM	Trupanion, Inc. Announces First Quarter 2024 Earnings Release and Conference Call (GlobeNewswire)
Apr-17-24 12:00PM	Trupanion Wins Silver Stevie Award in 2024 Stevie Awards for Sales & Customer Service (Business Wire)
Apr-16-24 09:00AM	Trupanion Publishes 2023 Annual Letter to Shareholders (GlobeNewswire)
Apr-02-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Trupanion, and Apple and Encourages Investors to Contact the Firm (GlobeNewswire)
04:05PM	Loading…
Mar-21-24 04:05PM	Trupanion Named 2024 Stevie Awards Finalist for Three Sales & Customer Service Categories (Business Wire)
Mar-12-24 03:38PM	The Three Most Undervalued Pet Stocks to Buy in March 2024 (InvestorPlace)
Mar-04-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm (GlobeNewswire) +6.34%
Feb-28-24 04:05PM	Trupanion to Participate in the Raymond James 2024 Institutional Investors Conference (GlobeNewswire)
Feb-22-24 09:30AM	Trupanion, Inc. Surpasses 1 Millionth Subscription Pet Milestone (GlobeNewswire)
04:00AM	13 Best Short Squeeze Stocks To Buy Now (Insider Monkey)
Feb-19-24 09:30AM	Trupanion to Participate in the Bank of America 2024 Financial Services Conference (GlobeNewswire)
Feb-18-24 03:41PM	3 Speculative Stocks That Could Make Your February Unforgettable (InvestorPlace)
Feb-16-24 08:38PM	Why Trupanion Stock Plummeted Today (Motley Fool) -35.15%
10:23AM	Trupanion, Inc. (NASDAQ:TRUP) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:41AM	Loading…
07:41AM	Q4 2023 Trupanion Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-15-24 05:21PM	Trupanion Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm (GlobeNewswire) +5.91%
04:55PM	Trupanion Inc (TRUP) Reports Accelerated Revenue Growth and Margin Expansion in Q4 and Full ... (GuruFocus.com)
04:41PM	Trupanion: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Trupanion Reports Fourth Quarter & Full Year 2023 Results (GlobeNewswire)
Feb-13-24 05:54PM	Trupanion Reconvenes Council on Animal Health; Provides Data-Driven Update on Mystery Canine Respiratory Illness (Business Wire)
Feb-08-24 09:00AM	Trupanion, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call (GlobeNewswire)
Jan-30-24 12:00PM	Trupanion Reconvenes Council on Animal Health to Provide Update on 'Mystery' Canine Respiratory Illness (GlobeNewswire)
Jan-22-24 07:44PM	7 Potential Short-Squeeze Stocks Poised for Rapid Gains (InvestorPlace)
Jan-09-24 12:31PM	Final Boarding Call: 3 Stocks Set for a Sky-High Surge (InvestorPlace)
12:00PM	Built In Honors Trupanion in its Esteemed 2024 Best Places to Work Awards (GlobeNewswire)
Dec-27-23 01:24PM	15 Best Pet Insurance Companies Heading into 2024 (Insider Monkey)
Dec-24-23 01:08PM	7 Short-Squeeze Stocks That Are Screaming for Speculation (InvestorPlace)
Dec-14-23 08:00PM	Statement from Aflac Incorporated and Trupanion Confirming Commitment to Strategic Alliance in North America (GlobeNewswire) +5.94%
Dec-07-23 04:20PM	Trupanion, leading pet medical insurance provider, teams up with renowned animal health experts to raise awareness around pet behavioral health (GlobeNewswire)
06:30AM	Loading…
Dec-04-23 06:30AM	Aflac and Trupanion Comment on Renewed S-3 Registration Statement Filed in Accordance with 2020 Shareholder Agreement (GlobeNewswire)
Dec-01-23 02:00AM	Trupanion, leading pet medical insurance provider, shares respiratory health data amid rising Canine Respiratory Illness concerns (GlobeNewswire) +14.15%
Nov-30-23 04:10AM	12 Best Pet Stocks to Buy Now (Insider Monkey) -6.61%
Nov-28-23 07:00AM	Global Veterinary Authorities Delve into Trupanion Data, Gaining Insight into Current Canine Respiratory Illness Concerns (GlobeNewswire)
Nov-23-23 03:49PM	7 Short-Squeeze Stocks That Could Serve Up Serious Rewards (InvestorPlace)
Nov-20-23 12:00PM	Supporting Your Pet's Behavioral Health During the Back-to-Office Transition: Join Trupanion's YouTube Premiere for Expert Guidance (GlobeNewswire) +5.98%
Nov-16-23 04:39AM	30 Smartest Animals in the World (Insider Monkey)
Nov-14-23 09:30AM	Trupanion's Holiday Safety Guide: Protecting Your Pets During Festive Seasons (GlobeNewswire) +11.28%
Nov-07-23 08:30AM	Trupanion Appoints Richard Enthoven, Global Entrepreneur and Founder of Hollard Insurance Company Australia, as Independent Board Director (GlobeNewswire)
Nov-06-23 09:55AM	Does Trupanion (TRUP) Have the Potential to Rally 38.83% as Wall Street Analysts Expect? (Zacks) -10.48%
Nov-03-23 04:03PM	Why Trupanion Stock Soared Today (Motley Fool) +14.30%
12:13PM	Trupanion, Inc. (NASDAQ:TRUP) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 07:38PM	Trupanion Inc (TRUP) Reports 22% Revenue Increase in Q3 2023 (GuruFocus.com) +11.78%
05:04PM	Resuming the Bull Market: 3 Top Ranked Stocks Investors Can Buy Now (Zacks)
04:53PM	Trupanion: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Trupanion Reports Third Quarter 2023 Results (GlobeNewswire)
09:35AM	Down -21.83% in 4 Weeks, Here's Why Trupanion (TRUP) Looks Ripe for a Turnaround (Zacks)
Oct-30-23 09:35AM	Trupanion (TRUP) Loses -26.63% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Oct-27-23 09:00AM	Trupanion Announces the Winners of its truFame Campaign (GlobeNewswire)
Oct-26-23 10:02AM	Trupanion (TRUP) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-17-23 04:05PM	Trupanion, Inc. Announces Third Quarter 2023 Earnings Release and Conference Call (GlobeNewswire)
Oct-16-23 09:00AM	Trupanion Celebrates National Veterinary Technician Week: Honoring the Heart of Veterinary Care (GlobeNewswire) +5.17%
Oct-10-23 10:50AM	Central Garden & Pet (CENT) Advances in 3 Months: Here's Why (Zacks)
Oct-06-23 12:07PM	Here's Why You Should Consider Investing in Trupanion (TRUP) (Zacks)
Oct-03-23 12:39PM	Trupanion (TRUP): A Smart Investment or a Value Trap? An In-Depth Exploration (GuruFocus.com) -6.00%
Sep-28-23 11:21AM	3 Prime-Catch Value Stocks to Snag on Nasdaqs Slide (InvestorPlace)
Sep-26-23 09:00AM	Trupanion to Participate in the Jefferies 2023 Virtual Pet Care & Wellness Conference (GlobeNewswire)
Sep-21-23 07:37PM	Is Trupanion (TRUP) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com) -10.07%
11:04AM	3 Stealth AI Stocks That Everyone Is Overlooking (InvestorPlace)
Sep-19-23 01:31PM	25 Best Dog Breeds for Children and Families (Insider Monkey)
Sep-06-23 09:00AM	Trupanion Announces Appointment of Fawwad Qureshi as Chief Financial Officer (GlobeNewswire)
Sep-02-23 07:24AM	Trupanion's Membership Is Soaring. Should You Buy the Stock? (Motley Fool)
Aug-29-23 04:32PM	3 Financial Stocks Due for a Massive Short Squeeze (InvestorPlace)
Aug-15-23 01:46PM	How Much Upside is Left in Trupanion (TRUP)? Wall Street Analysts Think 25.27% (Zacks)
Aug-09-23 09:00AM	Trupanion AI Technology Empowers Pet Parents with Lightning-Fast, Direct Hospital Payments (PR Newswire)
Aug-05-23 07:53AM	Trupanion, Inc. (NASDAQ:TRUP) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-03-23 08:00PM	Here's What Key Metrics Tell Us About Trupanion (TRUP) Q2 Earnings (Zacks)
05:55PM	Trupanion (TRUP) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:56PM	Trupanion: Q2 Earnings Snapshot (AP Finance)
04:05PM	Trupanion Reports Second Quarter 2023 Results (GlobeNewswire)
Aug-02-23 09:00AM	Trupanion to Participate in the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-31-23 04:14PM	Trupanion Expands Member Access Through New North American Hospital Group Partnerships (GlobeNewswire)
Jul-13-23 09:00AM	Trupanion, Inc. Announces Second Quarter 2023 Earnings Release and Conference Call (GlobeNewswire)
Jul-07-23 10:19AM	Trupanion (NASDAQ:TRUP) one-year losses have grown faster than shareholder returns have fallen, but the stock hikes 21% this past week (Simply Wall St.) +6.95%
Jul-05-23 09:00AM	Trupanion Appoints Aflac Incorporated CFO Max Brodén to Board of Directors (GlobeNewswire) +5.31%
Jun-30-23 04:00PM	Trupanion Provides Statement on New York Rate Filing Status (GlobeNewswire)
Jun-26-23 08:32AM	Trupanion (TRUP) Moves 9.9% Higher: Will This Strength Last? (Zacks)
Jun-23-23 01:38PM	Why Trupanion Stock Dropped 15.6% This Week (Motley Fool) +9.92%
Jun-22-23 07:08PM	These 2 Stocks Are Jumping Big After Hours Thursday (Motley Fool) -5.73%
04:15PM	Trupanion Provides Updates on Rate Filing Approval Status in California and New York (GlobeNewswire)
Jun-21-23 08:00PM	TRUP: Lowering target price to $23.00 (Argus Research) -17.98%
08:00PM	DXCM: Lowering target price to $23.00 (Argus Research)
05:50AM	1 Growth Stock Down 66% to Buy Right Now (Motley Fool)
Jun-15-23 04:05PM	Trupanion to Participate in the Jefferies 2023 Consumer Conference (GlobeNewswire)
Jun-13-23 09:01AM	Trupanion Launches truthankyou Program to Celebrate the Unsung Heroes of the Veterinary Community (GlobeNewswire)
May-25-23 09:00AM	Trupanion to Present at the Stifel 2023 Jaws & Paws Conference (GlobeNewswire)
May-20-23 07:24AM	Trupanion's Sales Are Surging on Puppy Love That Should Have Growth Investors Salivate (Motley Fool)
May-05-23 09:43AM	Q1 2023 Trupanion Inc Earnings Call (Thomson Reuters StreetEvents) -19.67%
May-04-23 07:00PM	Trupanion (TRUP) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
06:05PM	Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Trupanion: Q1 Earnings Snapshot (AP Finance)
04:05PM	Trupanion Reports First Quarter 2023 Results (GlobeNewswire)
Apr-28-23 09:00AM	Trupanion to Host 2023 Annual Meeting of Stockholders on June 7 (GlobeNewswire)
07:39AM	Trupanion (TRUP) Surges 9.0%: Is This an Indication of Further Gains? (Zacks)
Apr-27-23 04:05PM	Trupanion Appoints Paulette Dodson and Betsy McLaughlin to Board of Directors (GlobeNewswire) +8.95%
10:02AM	Analysts Estimate Trupanion (TRUP) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-26-23 08:00PM	DXCM: Lowering target price to $33.00 (Argus Research)
Apr-24-23 02:35PM	3 Pet Stocks That Could Purr in 2023 and Beyond (InvestorPlace)
Apr-19-23 08:08AM	Trupanion, Inc.'s (NASDAQ:TRUP) Stock Retreats 37% But Revenues Haven't Escaped The Attention Of Investors (Simply Wall St.)
Apr-13-23 04:37PM	Trupanion, Inc. Announces First Quarter 2023 Earnings Release and Conference Call (GlobeNewswire)

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAVIDSON JACQUELINE L	Director	Mar 31 '24	Option Exercise	0.00	1,055	0	13,402	Apr 03 07:20 PM
Dodson Paulette R.	Director	Mar 31 '24	Option Exercise	0.00	1,055	0	5,364	Apr 03 07:20 PM
MCLAUGHLIN ELIZABETH	Director	Mar 31 '24	Option Exercise	0.00	1,582	0	5,891	Apr 03 07:21 PM
Broden Max	Director	Mar 31 '24	Option Exercise	0.00	1,582	0	3,827	Apr 03 07:19 PM
Satchu Zay	Director	Mar 31 '24	Option Exercise	0.00	1,582	0	4,788	Apr 03 07:20 PM
LEVITAN DAN	Director	Mar 31 '24	Option Exercise	0.00	1,582	0	95,116	Apr 03 07:20 PM
RUBIN HOWARD E	Director	Mar 31 '24	Option Exercise	0.00	569	0	229,405	Apr 03 07:20 PM
RUBIN HOWARD E	Director	Dec 31 '23	Option Exercise	0.00	245	0	228,836	Jan 03 06:26 PM
LEVITAN DAN	Director	Dec 31 '23	Option Exercise	0.00	368	0	93,534	Jan 03 06:26 PM
Enthoven Richard	Director	Dec 31 '23	Option Exercise	0.00	485	0	485	Jan 03 06:26 PM
DAVIDSON JACQUELINE L	Director	Dec 31 '23	Option Exercise	0.00	245	0	12,347	Jan 03 06:27 PM
MCLAUGHLIN ELIZABETH	Director	Dec 31 '23	Option Exercise	0.00	1,560	0	4,309	Jan 03 06:27 PM
Broden Max	Director	Dec 31 '23	Option Exercise	0.00	1,141	0	2,245	Jan 03 06:28 PM
Satchu Zay	Director	Dec 31 '23	Option Exercise	0.00	368	0	3,206	Jan 03 06:27 PM
Dodson Paulette R.	Director	Dec 31 '23	Option Exercise	0.00	1,560	0	4,309	Jan 03 06:25 PM
LOW MURRAY B	Director	Dec 31 '23	Option Exercise	0.00	245	0	133,513	Jan 03 06:25 PM
WEINRAUCH STEVE	EVP, North Am & Vet Strategy	Dec 04 '23	Option Exercise	8.84	18,322	161,895	50,973	Dec 06 04:56 PM
WEINRAUCH STEVE	EVP, North Am & Vet Strategy	Nov 30 '23	Sale	26.11	10,170	265,518	32,651	Dec 04 01:15 PM
HEWITT MELISSA JOY	General Manager	Nov 30 '23	Sale	26.27	1,213	31,866	4,999	Dec 04 01:18 PM
Satchu Zay	Director	Sep 30 '23	Option Exercise	0.00	368	0	2,838	Oct 03 06:14 PM
RUBIN HOWARD E	Director	Sep 30 '23	Option Exercise	0.00	245	0	228,591	Oct 03 06:24 PM
MCLAUGHLIN ELIZABETH	Director	Sep 30 '23	Option Exercise	0.00	1,561	0	2,749	Oct 03 06:32 PM
LOW MURRAY B	Director	Sep 30 '23	Option Exercise	0.00	245	0	133,268	Oct 03 06:43 PM
DAVIDSON JACQUELINE L	Director	Sep 30 '23	Option Exercise	0.00	245	0	12,102	Oct 03 06:48 PM
LEVITAN DAN	Director	Sep 30 '23	Option Exercise	0.00	368	0	93,166	Oct 03 06:52 PM
Dodson Paulette R.	Director	Sep 30 '23	Option Exercise	0.00	1,561	0	2,749	Oct 03 06:56 PM
Broden Max	Director	Sep 30 '23	Option Exercise	0.00	1,104	0	1,104	Oct 03 07:00 PM
DOAK MICHAEL	Director	Aug 30 '23	Option Exercise	16.06	12,688	203,769	14,554	Sep 01 05:33 PM
DOAK MICHAEL	Director	Aug 30 '23	Sale	29.99	8,688	260,522	5,866	Sep 01 05:33 PM
LOW MURRAY B	Director	Jun 30 '23	Option Exercise	0.00	245	0	133,023	Jul 05 06:06 PM
LEVITAN DAN	Director	Jun 30 '23	Option Exercise	0.00	368	0	92,798	Jul 05 06:03 PM
Dodson Paulette R.	Director	Jun 30 '23	Option Exercise	0.00	1,188	0	1,188	Jul 05 06:00 PM
DAVIDSON JACQUELINE L	Director	Jun 30 '23	Option Exercise	0.00	245	0	11,857	Jul 05 05:58 PM
MCLAUGHLIN ELIZABETH	Director	Jun 30 '23	Option Exercise	0.00	1,188	0	1,188	Jul 05 06:09 PM
Satchu Zay	Director	Jun 30 '23	Option Exercise	0.00	368	0	2,470	Jul 05 06:15 PM
RUBIN HOWARD E	Director	Jun 30 '23	Option Exercise	0.00	245	0	228,346	Jul 05 06:13 PM
RAWLINGS DARRYL	Chief Executive Officer	May 08 '23	Sale	25.30	4,000	101,188	829,109	May 10 05:10 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

ADPT

Adaptive Biotechnologies Corp

TRUP

Trupanion Inc

Upgrade your FINVIZ experience